Skip to main content
Have a personal or library account? Click to login
Prevalence of Rheumatic Heart Disease in First-degree Relatives of Index-cases: A Systematic Review and Meta-Analysis Cover

Prevalence of Rheumatic Heart Disease in First-degree Relatives of Index-cases: A Systematic Review and Meta-Analysis

Open Access
|Mar 2025

References

  1. Vervoort D, Jin H, Edwin F, Kumar RK, Malik M, Tapaua N, et al. Global access to comprehensive care for paediatric and congenital heart disease. CJC Pediatr Congenit Heart Dis. 2023;2(6Part B):453463. DOI: 10.1016/j.cjcpc.2023.10.001
  2. Shah SN, Sharma S. Mitral Stenosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Mar 14]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK430742/.
  3. Ou Z, Yu D, Liang Y, Wu J, He H, Li Y, et al. Global burden of rheumatic heart disease: trends from 1990 to 2019. Arthritis Research & Therapy. 2022;24(1):138. DOI: 10.1186/s13075-022-02829-3
  4. Ralph AP, Noonan S, Wade V, Currie BJ. The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. Med J Aust. 2021;214(5):220227. DOI: 10.5694/mja2.50851
  5. Beaton A, Okello E, Rwebembera J, Grobler A, Engelman D, Alepere J, et al. Secondary antibiotic prophylaxis for latent rheumatic heart disease. N Engl J Med. 2022;386(3):230240. DOI: 10.1056/NEJMoa2102074
  6. Rothenbühler M, O’Sullivan CJ, Stortecky S, Stefanini GG, Spitzer E, Estill J, et al. Active surveillance for rheumatic heart disease in endemic regions: A systematic review and meta-analysis of prevalence among children and adolescents. Lancet Glob Health. 2014;2(12):e717726. DOI: 10.1016/S2214-109X(14)70310-9
  7. Muhamed B, Parks T, Sliwa K. Genetics of rheumatic fever and rheumatic heart disease. Nat Rev Cardiol. 2020;17(3):145154. DOI: 10.1038/s41569-019-0258-2
  8. Tormin JPAS, Nascimento BR, Sable CA, da Silva JLP, Brandao-de-Resende C, Rocha LPC, et al. Cytokine gene functional polymorphisms and phenotypic expression as predictors of evolution from latent to clinical rheumatic heart disease. Cytokine. 2021;138:155370. DOI: 10.1016/j.cyto.2020.155370
  9. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021 29;372:n71. DOI: 10.1136/bmj.n71
  10. Welch VA HJ. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). [Internet]. Available from: www.training.cochrane.org/handbook.
  11. Lawrence JG, Carapetis JR, Griffiths K, Edwards K, Condon JR. Acute rheumatic fever and rheumatic heart disease: Incidence and progression in the Northern Territory of Australia, 1997 to 2010. Circulation. 2013;128(5):492501. DOI: 10.1161/CIRCULATIONAHA.113.001477
  12. Meira ZMA, Goulart EMA, Colosimo EA, Mota CCC. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart. 2005;91(8):10191022. DOI: 10.1136/hrt.2004.042762
  13. Beaton A, Aliku T, Dewyer A, Jacobs M, Jiang J, Longenecker CT, et al. Latent rheumatic heart disease: Identifying the children at highest risk of unfavorable outcome. Circulation. 2017;136(23):2233. DOI: 10.1161/CIRCULATIONAHA.117.029936
  14. Engelman D, Wheaton GR, Mataika RL, Kado JH, Colquhoun SM, Remenyi B, et al. Screening-detected rheumatic heart disease can progress to severe disease. Heart Asia. 2016;8(2):67. DOI: 10.1136/heartasia-2016-010847
  15. Rwebembera J, Marangou J, Mwita JC, Mocumbi AO, Mota C, Okello E, et al. 2023 World Heart Federation guidelines for the echocardiographic diagnosis of rheumatic heart disease. Nat Rev Cardiol. 2024;21(4):250263. DOI: 10.1038/s41569-023-00940-9
  16. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al. Assessing risk of bias in prevalence studies: Modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012;65(9):934939. DOI: 10.1016/j.jclinepi.2011.11.014
  17. Schwarzer G, Carpenter JR, Rücker G. Meta-Analysis with R [Internet]. Cham: Springer International Publishing; 2015 [cited 2023 Oct 18]. (Use R!). Available from: https://link.springer.com/10.1007/978-3-319-21416-0.
  18. Aliku T, Sable C, Scheel A, Tompsett A, Lwabi P, Okello E, et al. Targeted echocardiographic screening for latent rheumatic heart disease in northern Uganda: Evaluating familial risk following identification of an index case. PLoS Negl Trop Dis. 2016;10(6):e0004727. DOI: 10.1371/journal.pntd.0004727
  19. Gemechu T, Parry EHO, Yacoub MH, Phillips DIW, Kotit S. Community-based prevalence of rheumatic heart disease in rural Ethiopia: Five-year follow-up. PLoS Negl Trop Dis. 2021;15(10):e0009830. DOI: 10.1371/journal.pntd.0009830
  20. Franco J, Nascimento BR, Beaton AZ, Oliveira KKB, Barbosa MM, Faria SCC, et al. Investigation of the Familial Risk of Rheumatic Heart Disease with Systematic Echocardiographic Screening: Data from the PROVAR+ Family Study. Pathogens. 2022;11(2):139. DOI: 10.3390/pathogens11020139
  21. Culliford-Semmens N, Tilton E, Wilson N, Stirling J, Doughty R, Gentles T, et al. Echocardiography for latent rheumatic heart disease in first degree relatives of children with acute rheumatic fever: Implications for active case finding in family members. EClinicalMedicine. 2021;37:100935. DOI: 10.1016/j.eclinm.2021.100935
  22. Carapetis JR, Beaton A, Cunningham MW, Guilherme L, Karthikeyan G, Mayosi BM, et al. Acute rheumatic fever and rheumatic heart disease. Nat Rev Dis Primers. 2016;2:15084. DOI: 10.1038/nrdp.2015.84
  23. Baker MG, Gurney J, Oliver J, Moreland NJ, Williamson DA, Pierse N, et al. Risk factors for acute rheumatic fever: Literature review and protocol for a case-control study in New Zealand. Int J Environ Res Public Health. 2019;16(22):4515. DOI: 10.3390/ijerph16224515
  24. Engel ME, Stander R, Vogel J, Adeyemo AA, Mayosi BM. Genetic susceptibility to acute rheumatic fever: A systematic review and meta-analysis of twin studies. PLoS One. 2011;6(9):e25326. DOI: 10.1371/journal.pone.0025326
  25. Poomarimuthu M, Ramasamy T, Govindan R, Andiappan R, Nagarajan G, Kadiam S, et al. Association of HLA-DRB1 alleles with rheumatic fever and rheumatic heart disease: A meta-analysis. Immunol Invest. 2022;51(2):221232. DOI: 10.1080/08820139.2020.1822864
  26. Kumar RK, Antunes MJ, Beaton A, Mirabel M, Nkomo VT, Okello E, et al. Contemporary diagnosis and management of rheumatic heart disease: Implications for closing the gap: A scientific statement from the American Heart Association. Circulation. 2020;142(20):e337e357. DOI: 10.1161/CIR.0000000000000921
  27. Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011; 3:6784. DOI: 10.2147/CLEP.S12977
  28. Gray LA, D’Antoine HA, Tong SYC, McKinnon M, Bessarab D, Brown N, et al. Genome-wide analysis of genetic risk factors for rheumatic heart disease in Aboriginal Australians Provides support for pathogenic molecular mimicry. J Infect Dis. 2017;216(11):14601470. DOI: 10.1093/infdis/jix497
  29. Study Details | GOALIE: Intramuscular vs. Enteral Penicillin Prophylaxis to Prevent Progression of Latent RHD Trial | ClinicalTrials.gov [Internet]. [cited 2024 Apr 22]. Available from: https://clinicaltrials.gov/study/NCT05693545.
  30. Gerber MA, Baltimore RS, Eaton CB, Gewitz M, Rowley AH, Shulman ST, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: A scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: Endorsed by the American Academy of Pediatrics. Circulation. 2009;119(11):15411551. DOI: 10.1161/CIRCULATIONAHA.109.191959
  31. Connolly SJ, Karthikeyan G, Ntsekhe M, Haileamlak A, El Sayed A, El Ghamrawy A, et al. Rivaroxaban in rheumatic heart disease-associated atrial fibrillation. N Engl J Med. 2022;387(11):978988. DOI: 10.1056/NEJMoa2209051
DOI: https://doi.org/10.5334/gh.1417 | Journal eISSN: 2211-8179
Language: English
Submitted on: Dec 18, 2024
Accepted on: Feb 24, 2025
Published on: Mar 10, 2025
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2025 Antonio Mutarelli, Guilherme Paes Gonçalves Nogueira, Alexandre Negrao Pantaleao, Alleh Nogueira, Bruna Giavina-Bianchi, Isabella M. Gonzalez Fonseca, Bruno R. Nascimento, Walderez O. Dutra, Robert A. Levine, Maria C. P. Nunes, On behalf of PRIMA Network, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.